Current self-pay terms
Wegovy cash prices depend on route, strength, fill, and date
The official Wegovy cost page viewed August 10, 2026 lists separate self-pay terms for pills and pens. It states that patients pay $149 for each month of 1.5 mg and 4 mg tablets, with the 4 mg offer available through August 31, 2026 and then listed at $199 per month. For patients new to the Wegovy Savings Offer or NovoCare Pharmacy, it lists $199 for each of the first two monthly fills of 0.25 mg or 0.5 mg pens through December 31, 2026, followed by $349 per month for listed standard pen strengths; Wegovy HD 7.2 mg is separately listed at $399 per month. These are temporary program terms, not universal retail prices or prescribing guidance.
- Match the offer to the exact tablet or injection prescription, strength, package, eligible fill, pharmacy channel, and date.
- Ask what the next fill is expected to cost after an introductory period, offer deadline, route change, strength change, or program cancellation.
- Recheck the live manufacturer page and processed pharmacy amount before every price-dependent decision because eligibility and terms can change.
Pill and pen identity
Current Wegovy includes tablets and injection presentations
The current Novo Nordisk DailyMed set, updated June 18, 2026, includes once-daily Wegovy tablets and subcutaneous injection presentations. A legitimate Wegovy tablet is therefore not automatically counterfeit, and Wegovy should not be described as injection-only. Still, a tablet price, pen price, authorization, routine, package, or refill rule cannot be transferred to the other route. Match the brand, dosage form, route, strength, prescription, package, and National Drug Code when available before comparing two cash quotes.
- The manufacturer defines a month as one bottle of 30 tablets or one box of four pens, but route-specific offers still have different strengths and conditions.
- Do not assume a tablet quote applies to a pen, Wegovy HD, Ozempic, Rybelsus, another semaglutide product, or compounded semaglutide.
- A lower price for an unlabeled vial, research product, different brand, membership, or compounded preparation is not a like-for-like Wegovy quote.
Insurance and cash-pay distinctions
No-insurance self-pay is different from a commercial savings card
The manufacturer also describes an as-little-as-$25 Wegovy offer for eligible patients using commercial prescription insurance, subject to a maximum savings of $100 per month and other terms; government beneficiaries are excluded. That commercial card is not the same as the self-pay pathway. True uninsured status, commercial coverage, a denied commercial claim, Medicare, Medicaid, TRICARE, VA or another government benefit should be represented accurately when checking lawful options.
- Do not assume that downloading a card establishes eligibility, coverage, medical approval, or the final amount due.
- If insurance denied the claim, request the written formulary, prior-authorization, step-therapy, exception, or appeal reason before choosing a cash pathway.
- Never hide government coverage, invent commercial insurance or a diagnosis, alter records, or use another patient’s card to obtain a price.
Complete cost of care
The medication price may exclude prescribing and monitoring costs
A manufacturer or pharmacy amount is not necessarily the total cost of Wegovy care. Depending on the patient and route, separate charges can include intake, medical-record review, laboratory work, clinician visits, medication, pharmacy dispensing, presentation-specific education, injection supplies when applicable, shipping, refill review, side-effect support, authorization help, and replacement or cancellation policies. A paid order or processed claim is not medical clearance or a guarantee of continued prescribing.
- Request an itemized first-fill estimate and an ongoing-fill estimate rather than comparing one introductory headline.
- Confirm whether clinician messaging, visits, laboratory review, supplies, shipping, refill support, replacements, and cancellation are included.
- Ask what happens financially if no prescription is issued, the product or presentation is unavailable, a shipment is damaged, or treatment stops.
If the quote is unaffordable
Review legitimate options without stretching doses or self-switching routes
If the current Wegovy quote is unaffordable, contact the prescriber and pharmacy before skipping, stretching, sharing, transferring, or replacing treatment. The clinician may review current official access options, a coverage or appeal path when insurance exists, another appropriately labeled medicine, a different licensed pharmacy, non-drug care, or a patient-specific compounded prescription only when clinically and legally appropriate. Compounded semaglutide is not FDA-approved Wegovy, not an FDA-approved generic, and not automatically interchangeable.
- Keep starting, stopping, switching, overlap, route changes, and refill timing clinician-directed rather than changing treatment only to match a price tier.
- If compounded care is discussed, verify the licensed prescriber, pharmacy, exact formulation, concentration, container, label, storage, beyond-use date, total cost, and follow-up.
- Do not split or stretch packages, share medication, transfer medicine between containers, buy loose powder, or follow copied dose-conversion or syringe charts.
Online seller checks
An unusually low Wegovy price can signal a product-identity problem
Wegovy requires a prescription and should come through a legitimate pharmacy. An advertised amount may apply to another route, strength, fill, pharmacy channel, insurance category, membership, country, or product. A seller that offers instant no-prescription checkout, hides the pharmacy, uses “research use only,” guarantees access, or calls an unlabeled vial generic Wegovy is not providing a trustworthy branded cash-pay pathway.
- Verify the web address, clinician license, pharmacy identity, prescription process, exact branded package, written terms, and final amount before paying.
- Avoid loose or counterfeit pens, unlabeled vials, marketplace resellers, social-media direct messages, peer-to-peer transfers, and crypto-only payment demands.
- Keep the carton or bottle, pharmacy label, receipt, lot information, storage record, and prescriber and pharmacy contacts for refill or adverse-event questions.